Steven Cohen Lexicon Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 4,121,191 shares of LXRX stock, worth $8.04 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,121,191
Previous 4,121,191
-0.0%
Holding current value
$8.04 Million
Previous $6.92 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding LXRX
# of Institutions
128Shares Held
240MCall Options Held
617KPut Options Held
286K-
Artal Group S.A. Luxembourg, N4175MShares$341 Million18.64% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$19.3 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.29MShares$16.2 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.68MShares$15 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.85MShares$11.4 Million0.24% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $368M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...